CK Legal has advised Selvita S.A. on its successfully allotment of 2.38 million of C series shares, raising EUR 20.6 million from investors.
Ipopema Securities S.A. was the global coordinator and bookrunner.
CK Legal describes Selvita as "one of the largest preclinical contract research organizations in Europe," and describes its share issuance as "the second largest transaction in terms of capital raised on the Warsaw Stock Exchange this year." According to the firm, "the issue was addressed to qualified and affluent investors (including packages worth over EUR 100,000). The offer was conducted in the ABB formula, which allowed for its closure within a few days."
According to a Selvita press release, "as part of the follow-on public offering of shares, investors could buy up to 2.38 million shares of the new C series, which constitutes about 15 percent of the current company’s share capital. The issue price of the shares was set at PLN 38.00. The company has achieved in full its intended goal regarding capital raise that was presented in the strategy published together with the announcement of the shareholders’ meeting.
The CK Legal team was led by Partner Wojciech Chabasiewicz and Anita Gwozdz.
